Table 1 Patient characteristics and baseline data
Characteristics | SAVR (n = 40) | TAVI (n = 32) | p value* |
|---|---|---|---|
Age | 72.8 ± 7.0 | 81 ± 6.3 | 0.001 |
Male gender, n (%) | 31 (78) | 20 (63) | 0.151 |
EuroSCORE II (%) | 1.53 ± 1.0 | 5.66 ± 5.6 | 0.001 |
STS Mortality (%) | 2.01 ± 0.6 | 5.68 ± 3.8 | 0.001 |
BMI (kgm−2) | 27.9 ± 6.3 | 26.6 ± 2.8 | 0.274 |
Systolic BP (mmHg) | 131 ± 23 | 127 ± 28 | 0.696 |
Diastolic BP (mmHg) | 73 ± 11 | 65 ± 11 | 0.003 |
Resting Heart Rate (bpm) | 64 ± 12 | 65 ± 11 | 0.713 |
NYHA class | 2.5 ± 0.6 | 3 ± 1.0 | 0.002 |
Previous MI, n (%) | 5 (13) | 6 (19) | 0.560 |
Previous PCI, n (%) | 1 (3) | 10 (31) | 0.001 |
Previous CABG, n (%) | 0 (0) | 12 (38) | 0.001 |
Stroke/TIA, n (%) | 7 (18) | 4 (13) | 0.667 |
Peripheral vascular disease, n (%) | 1 (3) | 6 (19) | 0.028 |
Diabetes Mellitus, n (%) | 4 (10) | 8 (25) | 0.125 |
Hyperlipidaemia, n (%) | 24 (60) | 20 (63) | 0.977 |
COPD, n (%) | 4 (10) | 6 (19) | 0.358 |
Atrial Fibrillation, n (%) | 1 (3) | 8 (25) | 0.006 |
eGFR (ml/min/1.73 m2) | 71.7 ± 13.3 | 61.4 ± 17.1 | 0.006 |
AVA (cm2) | 0.90 ± 0.5 | 0.62 ± 0.2 | 0.002 |
Mean PG (mmHg) | 43 ± 15.8 | 51 ± 13.7 | 0.023 |
LVEF (%) | 52 ± 12 | 52 ± 13 | 0.961 |
ValvuloArterial Impedance (Zva) | 3.88 ± 0.9 | 4.06 ± 1.6 | 0.982 |
Median prosthetic replacement size (mm) | 23 | 27 | 0.001 |
Sinuses of Valsalva dimension indexed to BSA (mm/m2) | 17.9 ± 2.2 | 18.1 ± 2.1 | 0.615 |
Proximal ascending aortic dimension indexed to BSA (mm/m2) | 17.4 ± 2.8 | 16.9 ± 2.8 | 0.505 |